Next-Generation ADCs: Unlocking the Potential of CEACAM6-Directed Targeted Therapies

  • Examining CEACAM6 as a tumour-specific target in hard-to-treat solid tumours
  • Leveraging cutting edge ADC design to achieve precise targeting with broad therapeutic potential
  • Building state-of-the-art ADC constructs targeting CEACAM6